Compensated Awareness Post View
Disclaimer
$PLPL today news on the prostrate and last week they giving updates on Their green tea for Alzheimer's disease
BALTIMORE, MD--(Marketwired - Jun 6, 2013) - Goldman Small Cap Research, a stock market research firm focused on the small cap and microcap sectors, reports that a recent study published in in the Journal of Biology Chemistry found that Epigallocatechin gallate (EGCG) has demonstrated the ability to serve as a treatment for Alzheimer's disease, which could serve as a major positive for Plandai. EGCG is the most abundant catechin found in green tea and serves as a key component of the Company's flagship offering. Plandai Biotechnology is a developer of highly bioavailable, phytonutrient rich extracts (like EGCG), which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions.